INTERFERON ALFA-2A for Malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 14 adverse event reports in the FDA FAERS database where INTERFERON ALFA-2A was used for Malignant melanoma.
Most Reported Side Effects for INTERFERON ALFA-2A
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 77 | 13.0% | 17 | 15 |
| Anaemia | 65 | 11.0% | 10 | 13 |
| Drug ineffective | 60 | 10.1% | 3 | 17 |
| Nausea | 46 | 7.8% | 6 | 10 |
| Thrombocytopenia | 43 | 7.3% | 9 | 10 |
| Off label use | 42 | 7.1% | 7 | 17 |
| Pyrexia | 41 | 6.9% | 6 | 15 |
| Weight decreased | 40 | 6.8% | 10 | 7 |
| Depression | 39 | 6.6% | 9 | 2 |
| Neutropenia | 39 | 6.6% | 7 | 5 |
| Leukopenia | 33 | 5.6% | 2 | 6 |
| Hepatitis c | 32 | 5.4% | 2 | 3 |
| Headache | 27 | 4.6% | 1 | 7 |
| Vomiting | 26 | 4.4% | 6 | 5 |
| Influenza like illness | 24 | 4.1% | 2 | 2 |
Other Indications for INTERFERON ALFA-2A
Hepatitis c (151)
Product used for unknown indication (65)
Chronic hepatitis c (60)
Renal cell carcinoma (48)
Metastatic renal cell carcinoma (45)
Cutaneous t-cell lymphoma (19)
Chronic myeloid leukaemia (16)
Hairy cell leukaemia (16)
B-cell lymphoma (12)
Behcet's syndrome (12)
Other Drugs Used for Malignant melanoma
NIVOLUMAB (10,599)
IPILIMUMAB (8,903)
DABRAFENIB (5,277)
TRAMETINIB DIMETHYL SULFOXIDE (3,841)
PEMBROLIZUMAB (3,261)
BINIMETINIB (2,613)
ENCORAFENIB (2,591)
VEMURAFENIB (2,548)
TRAMETINIB (1,448)
COBIMETINIB (1,324)